Tuesday, October 4, 2011

Crestor Side Effects Too Weighty to Risk?


Statins are the best-selling drugs in the United States, with $14.5 billion in combined sales in 2008. They use the liver to block the body’s creation of cholesterol, which is a key contributor to coronary artery disease. Statin is used in a number of popular cholesterol controlling drugs, including Crestor, Lipitor, Zocor, Mevacor, Lescol and Pravachol. Within two months of Crestor hitting the shelves serious harmful and dangerous side effects were brought to surface by those taking the drug. Not long after taking the prescription drug some patients began suffering a number of different harmful and dangerous side effects of Crestor.

Some other patients who had taken the prescription drug Crestor began to suffer from acute kidney failure. This is a condition that causes the kidney to fail, which is an instantly dangerous condition. When this happens several steps need to initiated immediately to avoid the risk of death. Some of these procedures include the removal of the kidney, kidney dialysis therapy and more. Other patients who have used the prescription drug reported Crestor cardiomyopothy, and
development of a chronic bleeding condition that continued to the point where they needed to seek medical assistance to stop the bleeding, among other serious issues. It didn’t take long for doctors to figure out that it was Crestor that was causing these condition.

The FDA approved the drug for sale in the United States in 2003 and the company AstraZeneca began marketing the drug as the strongest cholesterol prescription on the market. AztraZeneca started out with a bang and funded an enormous marketing and national advertising campaign spanning all forms of media from television, radio and internet. This campaign brought in huge revenues for the pharmaceutical giant.  Currently many patients who have suffered harmful side effects of Crestor are seeking experienced pharmaceutical legal council, and may pursue a Crestor lawsuit.

No comments:

Post a Comment